Sleep Disorders Trial, Recruiting NCT07399964 Sponsor: The University of Hong Kong Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07399964
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are Chinese and between 12 and 24 years old
  • People who have been diagnosed with insomnia disorder based on standard diagnostic guidelines (called DSM-V), and who score 9 or higher on a recognised insomnia questionnaire called the Insomnia Severity Index
  • People who are willing to follow the study plan and attend what is required
  • People aged under 18 must have a parent or guardian who also agrees in writing to their participation, alongside the young person's own written agreement

Who may not be able to join:

  • People who currently have a diagnosis of substance abuse or dependence, or who have a current or past history of certain mental health conditions, including manic or hypomanic episodes, schizophrenia-related conditions, neurodevelopmental disorders, brain-based (organic) mental disorders, or intellectual disabilities
  • People who have a significant physical health condition known to affect sleep quality, such as eczema or acid reflux
  • People who have been clinically diagnosed with another sleep disorder (separate from insomnia), such as narcolepsy, breathing problems during sleep, or restless leg syndrome
  • People who regularly take any medications — whether prescription, over-the-counter, or traditional remedies (including melatonin or Traditional Chinese Medicine) — that are known to affect sleep quality
  • People whom the research clinician considers to have a significant level of suicidal thinking, particularly where there is a plan or a previous attempt
  • People who are currently receiving any psychological therapy or treatment for insomnia
  • People who have a hearing or speech difficulty
  • People who work night shifts

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 39177035

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 June 2024
Est. completion
1 December 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

Change in Impulsivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov